Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorisation for the product Cyanocobalamin 50mg film coated tablets from UK MHRA. Earlier, the company’s wholly owned subsidiary -- Time-Cap Laboratories, Inc. had received Establishment Inspection Report (EIR) from US Food & Drugs Administration (USFDA) for audit conducted in October 2023. No 483's were issued during the Audit.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.
